Clik here to view.
Acelity Announces Exchange Offer and Consent Solicitation with Respect to...
SAN ANTONIO Acelity L.P. Inc. (“Acelity”), a global advanced wound care and regenerative medicine company, announced today that its wholly-owned subsidiaries, Kinetic Concepts, Inc. (“KCI”) and KCI...
View ArticleClik here to view.
Clik here to view.
Kansas University Medical Center and Baylor Scott & White Research Institute...
SEATTLE Nativis, Inc., a clinical stage life sciences bio-electronics company developing non-invasive, medical device treatments for cancers and other serious diseases, today announced its latest...
View ArticleClik here to view.
Acelity Launches PREVENA PLUS™ Incision Management System with Customizable...
SAN ANTONIO Acelity, a global wound care and regenerative medicine company, today announced the expansion of its PREVENA™ Therapy portfolio with the global launch of the PREVENA PLUS™ Incision...
View ArticleClik here to view.
GORE® VIABAHN®内假体庆贺20载可靠功效
亚利桑那州弗拉格斯塔夫 (美国商业资讯) — W. L. Gore & Associates, Inc. (Gore)正在庆贺GORE® VIABAHN®内假体上市20周年，这种市场领先的支架-移植物用于治疗复杂型周围血管疾病。该器械经过工程设计，可有效覆盖和封堵病变组织，为医生处治挑战性的复杂型病灶提供管腔内旁路选择。该器械于1996年率先在欧洲植入，以往的名称是GORE®...
View ArticleClik here to view.
GORE® VIABAHN® Endoprosthesisが定評のある性能を提供して20年
米アリゾナ州フラッグスタッフ （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は、複雑な末梢血管疾患の治療に使用するステントグラフトとして市場をリードするGORE® VIABAHN®...
View ArticleClik here to view.
Starpharma: VivaGel® Condom Receives Regulatory Approval in Canada
MELBOURNE, Australia Starpharma Holdings Ltd (ASX: SPL) (OTCQX: SPHRY) today announced it had been granted a medical device license for the VivaGel® condom by the Canadian regulatory authority,...
View ArticleClik here to view.
Ignyta to Present at 2016 Silicon Valley Bank Healthcare Capital and...
SAN DIEGO Ignyta, Inc. (Nasdaq: RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jacob Chacko, M.D., its Chief Financial Officer, will make a...
View ArticleClik here to view.
10x Genomics Accelerates Asia Pacific Expansion with Japanese Distributor...
PLEASANTON, Calif. 10x Genomics, Inc., a company focused on expanding genomics applications by providing researchers with access to critical longrange genomic information and gene expression at...
View ArticleClik here to view.
GORE® TAG®胸主动脉血管内覆膜支架的枢纽性研究完成首例植入
亚利桑那州弗拉格斯塔夫 (美国商业资讯) — W. L. Gore & Associates, Inc. (Gore)今天宣布，GORE® TAG®胸主动脉血管内覆膜支架(TBE)的枢纽性研究完成首例植入。入组该例患者的是Himanshu Patel, MD，他是密西根大学佛兰克尔心血管中心成人心脏外科的分科主任和该研究的联席全国主要研究者。 Smart News...
View ArticleClik here to view.
GORE® VIABAHN® Endoprosthesisが複雑なSFA疾患の治療で最適なデバイスであることを日本での臨床研究の1年成績が確認
米アリゾナ州フラッグスタッフ & ラスベガス （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は本日、GORE® VIABAHN® Endoprosthesis with Heparin Bioactive...
View ArticleClik here to view.
日本临床研究1年结果证实，GORE® VIABAHN®血管内覆膜支架是治疗SFA复杂型病变的首选器械
亚利桑那州弗拉格斯塔夫和拉斯维加斯 (美国商业资讯) — W. L. Gore & Associates, Inc. (Gore)今天发布了配备肝素生物活性涂层*的GORE®...
View ArticleClik here to view.
One-Year Results in Japanese Clinical Study Affirms the GORE® VIABAHN®...
FLAGSTAFF, Ariz. & LAS VEGAS W. L. Gore & Associates, Inc. (Gore) today announced positive results from a prospective, multicenter Investigational Device Exemption (IDE) Clinical Study of...
View ArticleClik here to view.
Acelity Announces Early Tender Results for the Exchange Offer and Successful...
SAN ANTONIO Acelity L.P. Inc. (“Acelity”), a global advanced wound care and regenerative medicine company, today announced the results, as of 5:00 p.m., New York City time, on September 19, 2016...
View ArticleClik here to view.
施乐辉公司在世界伤口愈合学会联盟会议(WUWHS)上加强对高级伤口处治宣教的坚定承诺
伦敦 (美国商业资讯) — 全球性医疗技术巨头施乐辉公司(LSE:SN) (NYSE:SNN)在2016年9月25-29日于意大利佛罗伦萨召开的世界伤口愈合学会联盟会议(WUWHS)上赞助了3场科学研讨会。这些研讨会加强了施乐辉公司的承诺，即通过开展并有效传播能为患者提供更佳转归的临床实践领域的研究来支持医疗保健专业人员。...
View ArticleClik here to view.
GORE® TAG® Thoracic Branch Endoprosthesisのピボタル試験で初の植え込みが完了
米アリゾナ州フラッグスタッフ （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は本日、ピボタル試験でGORE® TAG® Thoracic Branch...
View ArticleClik here to view.
SAB Biotherapeutics的免疫治疗药物提案跻身WHO报告中的顶级平台技术解决方案之列
马里兰州贝塞斯达和南达科他州苏福尔斯 (美国商业资讯) — 临床阶段生物制药开发企业SAB Biotherapeutics (SAB)今天宣布，其DiversitAb人类抗体生产平台被确认为世界卫生组织(WHO)针对有大流行可能的优先感染性疾病的平台技术公开磋商中涌现的6个最有价值提案之一，该平台发挥了转染色体牛(Tc Bovine™)的优势。...
View ArticleClik here to view.
Clik here to view.
GE Healthcare Aims to Fund up to $50M for Global Health Startups
BANGALORE, India GE Healthcare, the $18 billion healthcare technology division of GE (NYSE: GE), today announced the launch of the company’s first healthcare accelerator, five.eight, aimed at...
View ArticleClik here to view.
SAB Biotherapeuticsの免疫療法に関する提案がWHO報告書で優秀なプラットフォーム技術ソリューションの1つに選ばれる
米メリーランド州ベセスダ & 米サウスダコタ州スーフォールズ （ビジネスワイヤ） — 臨床段階のバイオ医薬品開発企業SAB Biotherapeutics（SAB）は本日、染色体導入ウシ（Tc...
View Article